Systemic cytokine response after major surgery

British Journal of Surgery

Volumn 79, Issue 8, 1992, Pages 757-760

  Baigrie, R J ^a   Lamont, P M ^a   Kwiatkowski, D ^a   Dallman, M J ^a   Morris, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HERNIA; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM; C-REACTIVE PROTEIN; FEMALE; HERNIA, INGUINAL; HUMAN; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGE; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0026649080     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800790813     Document Type: Article

References (29)

1. The influence of surgical operations on components of the human immune system
2. Epidemiology of trauma patients
3. Host defence mechanisms in elective and emergency vascular surgery: predicting sepsis‐related mortality
4. Interleukin‐1
5. Interleukin‐6. The major regulator of acute‐phase protein synthesis in man and rat
6. Interferon β2/B cell stimulatory factor 2 shares identity with monocyte‐derived hepatocyte‐stimulating factor and regulates the major acute phase protein response in liver cells
7. Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis
8. Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression
9. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation
10. Regulation of interleukin‐6 expression in cultured human blood monocytes and monocyte‐derived macrophages
11. Induction of beta 2‐interferon by tumour necrosis factor: a homeostatic mechanism in control of cell proliferation
12. Interleukin‐1 induces interleukin‐6 production in peripheral blood monocytes
13. Endotoxin, tumour necrosis factor‐alpha and interleukin‐1 induce interleukin‐6 production in vivo
14. Detection of circulating tumor necrosis factor after endotoxin administration
15. The serum interleukin‐6 response to elective surgery
16. TNF concentration in fatal cerebral, non‐fatal cerebral and uncomplicated Plasmodium falciparum malaria
17. Analysis of serial measurements in medical research
18. Interleukin‐1 receptor antagonist activity of a human interleukin‐1 inhibitor
19. Tumor necrosis factor and interleukin‐1 in serum of children with severe infectious purpura
20. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
21. Response of serum interleukin‐6 in patients undergoing elective surgery of varying severity
22. The relationship between the circulating concentrations of interleukin 6 (IL‐6), tumour necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury
23. Increased plasma levels of interleukin‐6 in sepsis
24. Plasma tumour necrosis factor and mortality in critically ill septic patients
25. Prognostic values of tumour necrosis factor/cachectin, interleukin‐1, interferon alpha, and interferon gamma in the serum of patients with septic shock
26. Early time course of the acute phase protein response in man
27. Acute phase protein response to tissue injury
28. Induction of rat acute phase proteins by interleukin‐6 in vivo
29. IL‐6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL‐6